Haapasalo Joonas, Hyartt Antti, Salmi Minja, Nordfors Kristiina, Lahtela Sirpa-Liisa, Kähkönen Marketta, Helén Pauli, Haapasalo Hannu
Duodecim. 2014;130(9):893-901.
Gliomas are tumors of the support cells of the brain and the most common of the primary brain tumors. Treatment of diffuse gliomas is based on surgical excision of the tumor and on radiotherapy and chemotherapy. The diagnosis is made in histopathological examination of the tumor, which today can be complemented with examinations involving molecular diagnostics. The most important new methods predicting the prognosis of glioma patients include demonstrations of the IDH mutation and the 1p/19q co-deletion. Profiling of gliomas may in the future allow tailoring of therapy in a patient-specific manner.
神经胶质瘤是脑支持细胞的肿瘤,也是最常见的原发性脑肿瘤。弥漫性神经胶质瘤的治疗基于肿瘤的手术切除以及放疗和化疗。诊断通过肿瘤的组织病理学检查做出,如今还可辅以分子诊断检查。预测神经胶质瘤患者预后的最重要的新方法包括IDH突变和1p/19q共缺失的检测。未来,神经胶质瘤的分析可能会实现针对患者的个性化治疗。